Skip to main content
# Title Department Research Member Research Year
21 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Amany Mohammed Abdel Moatamed 2024
22 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023
23 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
24 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Sanaa Saber Abdelraheem Barakat 2023
25 Efficacy of pectoralis plane block versus wound instillation using ketamine with bupivacaine on postoperative analgesia following modified radical mastectomy, a randomized study Department of Anesthesia, Intensive care and Pain management Dr. Ahmad Mohammad Abd El-Rahman 2023
26 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
27 Intracardiac Extension of Malignant Tumors: A Case Series with Seven Cases Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed 2023
28 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
29 Systemic Analgesia versus Continuous Erector Spinae Plane Block (ESPB) Infusion during Paediatric Nephrectomy: A Randomized, Controlled Trial Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2023
30 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023